Which has the lower trailing P/E, IDXX or TEVA?

IDXX has the lower trailing P/E: IDXX trades at 38.60 and TEVA at 62.70. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, IDXX or TEVA?

Over the past five years, IDXX grew revenue faster — IDXX at a 8.37% CAGR versus TEVA at 1.19%.

Is IDXX or TEVA more profitable?

IDXX runs the higher net margin — IDXX at 25.03% versus TEVA at 4.08%.

How have IDXX and TEVA total returns compared?

Over the past 10 years, IDXX delivered 17.34% and TEVA delivered -2.70% annualized total return. Past performance doesn't predict future results.

IDEXX Laboratories, Inc. (IDXX) vs Teva Pharmaceutical Industries Limited (TEVA)

A side-by-side comparison of IDEXX Laboratories, Inc. and Teva Pharmaceutical Industries Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 28, 2026. Differences are shown without an overall score or investment verdict.

IDXX

IDEXX Laboratories, Inc.

$43.47B

$551.12HealthcareDelayed quote: Aug 28, 2026, 12:25 PM EDT

TEVA

Teva Pharmaceutical Industries Limited

$42.59B

$36.57HealthcareDelayed quote: Aug 28, 2026, 12:25 PM EDT

Total return — IDXX vs TEVA

growth of $100 · dividends reinvested · last 10y

IDXX +375.0% (+16.9%/yr)TEVA -23.5% (-2.6%/yr)IDXX compounded faster over this window

Log scale — wide-divergence pair

IDXX TEVA

IDXX vs TEVA: by the numbers

•IDXX is the larger company ($43.47B vs $42.59B market cap).
•IDXX trades at the lower trailing earnings multiple (38.60 vs 62.70 P/E), one valuation lens rather than an overall verdict.
•IDXX converts more revenue to profit (25.03% vs 4.08% net margin).
•IDXX grew revenue faster over the past five years (8.37% vs 1.19% CAGR).

Metrics side by side

Valuation

Metric	IDXX	TEVA
P/E ratio	38.60	62.70
Forward P/E	36.90	18.80
P/S ratio	9.66	2.57
P/B ratio	27.27	5.73
EV / EBITDA	27.83	19.40
FCF yield	2.84%	3.03%

Profitability

Metric	IDXX	TEVA
Gross margin	62.45%	52.47%
Operating margin	32.03%	11.45%
Net margin	25.03%	4.08%
ROE	70.67%	9.10%
ROIC	41.33%	6.79%

Growth (annualized)

Metric	IDXX	TEVA
Revenue CAGR (5Y)	8.37%	1.19%
EPS CAGR (5Y)	14.07%	N/A
FCF CAGR (5Y)	12.49%	14.58%
Total return CAGR (5Y)	-3.99%	32.11%

Frequently asked

Which has the lower trailing P/E, IDXX or TEVA?: IDXX has the lower trailing P/E: IDXX trades at 38.60 and TEVA at 62.70. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, IDXX or TEVA?: Over the past five years, IDXX grew revenue faster — IDXX at a 8.37% CAGR versus TEVA at 1.19%.
Is IDXX or TEVA more profitable?: IDXX runs the higher net margin — IDXX at 25.03% versus TEVA at 4.08%.
How have IDXX and TEVA total returns compared?: Over the past 10 years, IDXX delivered 17.34% and TEVA delivered -2.70% annualized total return. Past performance doesn't predict future results.

Go deeper

Full IDXX analysis Full TEVA analysis Interactive comparison tool

Dig into the metrics

IDEXX Laboratories P/E ratio Teva Pharmaceutical Industries P/E ratio IDEXX Laboratories ROE Teva Pharmaceutical Industries ROE IDEXX Laboratories operating margin Teva Pharmaceutical Industries operating margin IDEXX Laboratories revenue growth Teva Pharmaceutical Industries revenue growth IDEXX Laboratories free cash flow Teva Pharmaceutical Industries free cash flow

IDEXX Laboratories & Teva Pharmaceutical Industries appear in these rankings

Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 28, 2026.